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Abstract
Introduction: Tuberculous pleural effusions are not always easy to diagnose but the presence of
a lymphocyte-rich exudate associated with an increased adenosine deaminase level and a positive
skin test result are highly sensitive diagnostic signs.
Case presentation: We report a case of pleural tuberculosis in a 31-year-old white male patient
from Caracas, Venezuela who was negative for human immunodeficiency virus and presented 2
weeks after injecting the anabolic-androgenic steroid nandrolone decanoate, in whom all the tests
for tuberculosis were initially negative; an eosinophilic pleural effusion with a low adenosine
deaminase level, a negative tuberculin skin test and negative for acid-fast bacilli staining and culture
of the pleural fluid. After excluding other causes of eosinophilic pleural effusion malignant pleural
effusion was suspected. The patient did not return until 4 months later. The second thoracentesis
obtained a pleural fluid suggestive for tuberculosis, with a predominance of lymphocytes, an
elevated adenosine deaminase level (51 U/l) and a positive tuberculin skin test. Culture of pleural
fragments confirmed pleural tuberculosis.
Conclusion: This case suggests that the use of an anabolic-androgenic steroid masks the definitive
diagnosis of pleural tuberculosis by changing the key diagnostic parameters of the pleural fluid, a
finding not previously reported. Available evidence of the effects of anabolic steroids on the
immune system also suggests that patients using anabolic-androgenic steroids might be susceptible
to developing tuberculosis in either reactivating a latent infection or facilitating development of the
disease after a recent infection.
Introduction
The cause of an exudative pleural effusion (EPF) is often
difficult to determine, but tuberculosis (TB) must be con-
sidered, especially in countries with a high prevalence of
TB. The diagnosis of a tuberculous pleural effusion is
based on the Ziehl-Neelsen staining for acid-fast bacilli
(AFB) and on the growth of Mycobacterium tuberculosis
from pleural fluid or biopsy. However, if no AFB are
found, cultures take 4–6 weeks to be positive, and thera-
peutic decisions need to be made before the results are
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helpful, but may be negative in a third of the patients with
tuberculous pleural effusions. An elevated level of the
Adenosine Deaminase (ADA) activity in the pleural fluid
has proven to be very sensitive and specific for the diagno-
sis of pleural TB, specially when the differential cell count
of an exudative effusion shows a lymphocyte neutrophil
ratio of 0.75 or greater [1,2]. We report a case of pleural TB
in a patient who presented 2 weeks after injecting the
androgenic-anabolic steroid (AAS) nandrolone
decanoate, in whom all the tests for TB were initially neg-
ative. This case report reviews the possible effects of AAS
therapy on the immune system and changing important
diagnostic parameters in the pleural fluid.
Case presentation
A 31-year-old white man from Caracas, Venezuela pre-
sented in the emergency room complaining of daily
evening fever, night sweats, pleuritic chest pain and short-
ness of breath for the previous 2 weeks. Up until 2-weeks
before, over 10 days, he had received a daily dose of intra-
muscular nandrolone (Deca-Durabolin® 50 mg), but was
not taking any other medication. A chest X-ray showed a
pleural effusion occupying 30% of the left hemi-thorax.
His physical examination, blood count and serum bio-
chemistry were otherwise unremarkable. A thoracentesis
obtained clear fluid, exudative by lactate dehydrogenase
(LDH) and protein levels, (310 UI/l and 4,8 gr/dl respec-
tively) normal pH (7,46) and predominantly eosinophils
(30%) in the leukocyte differential count (2500 cell per
cubic milliliter) and 50% lymphocytes and 20% neu-
trophils. No peripheral blood eosinophilia was found.
AFB staining of the pleural fluid was negative and the ADA
level was normal (21 UI/L). The patient gave no history of
TB contact and a TST was negative (0 mm). Culture of the
pleural fluid for bacteria on blood agar and for mycobac-
teria on Lowenstein Jensen and Stonebrink medium was
negative. A parasitic infection was suspected but serial
stool examinations were negative for parasites. No defini-
tive diagnosis was made, but malignant pleural effusion
was suspected.
After thoracentesis the patient felt better and did not
return to the hospital until 4-months later, when he
returned to the emergency room with similar pleuritic
symptoms, fever and night sweats. Additionally, he had a
nonproductive cough and had lost more than 5 kilograms
in weight since the previous visit. Examination of the
lungs revealed decreased breath sound in the lower left
hemi-thorax, but the rest of the physical examination was
normal. A chest X-ray again showed the left sided pleural
effusion, slightly smaller than on the previous study. A
second thoracentesis obtained turbid fluid, pH 7·41,
3100 cells per cubic millimeter, 90% mononuclear and
3% eosinophils, 5,4 gr/dl proteins and 242 UI/dl LDH.
Glucose, amylase levels, hematological parameters, renal
and hepatic serum tests were normal. The effusion/serum
ratio for proteins and LDH were 0·77 and 0·83 respec-
tively. The ADA on the pleural fluid was elevated (51 U/L)
and suggestive of tuberculosis, and the TST was positive
(20 mm). Ziehl-Neelsen staining for AFB was negative
both on induced sputum and pleural liquid. A pleural
biopsy showed a chronic pleurisy with multiple granulo-
mas with central necrosis, compatible with pleural TB and
a culture of the pleural tissue was positive for M. tubercu-
losis after 4 weeks. The patient's symptoms disappeared
after starting treatment with anti-tuberculosis drugs, and
the chest X-ray showed resolution of the effusion 4 weeks
later, turning completely normal.
Discussion
Two weeks after anabolic steroid use our patient had a
pleural effusion that was predominantly eosinophilic.
Pleural fluid eosinophilia is very often related with condi-
tions associated with the presence of blood or air in the
pleural space [3] but our patient had no evidence of chest
trauma, hemothorax, or pneumothorax. Pulmonary
embolism or benign asbestos pleural effusions are other
common causes of eosinophilic pleural effusion, but were
also excluded, even as a parasitic or bacterial infection [3].
The relationship between symptom onset and initiation
of AAS therapy in combination with the pleural fluid eosi-
nophilia raised the suspicion of a drug-induced pleural
reaction (reviewed in [4]). Certain drugs (Table 3 in [3])
can cause pleural eosinophilia. However, most of these
drugs also cause peripheral eosinophilia which was not
found in our patient. In addition, AAS are not listed as
drugs that cause eosinophilic pleurisy. Because the fre-
quency of malignant etiology among EPEs in general is
high and has varied between 6% and 40% in different
studies [3] malignancy was suspected. We did not con-
sider a tuberculous pleural effusion as they very rarely
contain high numbers of eosinophils. A prevalence of
only 1·3% among 700 tuberculous pleural effusions has
been reported [5]. In addition, the patient had a negative
TST and pleural liquid with a normal ADA value, two
important other parameters for the consideration of
tuberculous pleurisy [1,2]. These three parameters how-
ever were strikingly changed at the second visit 4-months
later, when the TST was positive, the pleural fluid was pre-
dominantly lymphocytic, the ADA level was elevated and
tuberculous pleurisy was diagnosed.
Only a few data are available about the effects of anabolic
steroids on the immune system and therefore do not
allow firm conclusions but we hypothesize that the use of
nandrolone could have changed the key parameters of the
pleural fluid, and could have played a role in developing
tuberculosis in either reactivating a latent infection or
facilitating development of disease after a recent infection.Page 2 of 3
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It has been shown that a high dose of anabolic steroids
can have significant effects on immune responses. Nan-
drolone decanoate directly modifies the cytokine pattern
in human and murine models increasing the production
of inflammatory cytokines IL-1 beta and TNF-alpha, with-
out affecting IL-2 or IL-10 production but significantly
inhibiting IFN gamma production [6] This last cytokine is
essential in monocyte and macrophage Th1 activation,
the most effective response against intracellular patho-
gens like M. tuberculosis. In addition, IFN gamma is a
potent inductor of intracellular ADA [7] and the low level
of ADA activity found in the pleural liquid just after the
use of nandrolone decanoate could have been caused by
the inhibitor effect of the AAS on the IFN production. This
model however doesn't explain the high level of eosi-
nophils in the pleural space just after AAS use. An eosi-
nophilic pleural effusion is supposed to be related to IL-5
production [8], and no relation has been described
between AAS and IL-5 production to explain the high level
of eosinophils in the pleural space.
In conclusion, we believe that the use of AAS should be
included when evaluating EPEs and should be considered
a possible cause of changing pleural fluid parameters and
of developing TB. It is important to stress that, as has been
observed for the reactivation of TB after the use of for
example glucocorticosteroids [9], the frequency of devel-
oping TB could be low in countries with a low incidence
of TB (for glucocorticosteroids, 0% in the USA and Greece,
0·6% in France and 1·35% in Spain have been reported).
In contrast, the frequency of development of TB after the
use of glucocorticosteroids was much higher in studies
performed in countries with a moderate to high incidence
of TB (from 2·5% in South Korea to 13·8% in the Philip-
pines [9]).
Conclusion
This case suggests that patients using anabolic steroids
might be susceptible to developing tuberculosis in either
reactivating a latent infection or facilitating development
of disease after a recent infection and that the use of nan-
drolone limits the diagnostic value of key parameters for
the diagnosis of pleural TB, a finding not previously
reported. We would like to recommend that attention
should be paid to the possibility of nandrolone as a drug
implicated in tuberculous eosinophilic pleurisy.
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